History
  • No items yet
midpage
Reed v. Pfizer, Inc.
2012 U.S. Dist. LEXIS 35227
E.D.N.Y
2012
Read the full case

Background

  • Plaintiffs Reed allege injury from ingesting Lybrel, manufactured and sold by Pfizer and Wyeth.
  • Initial complaint and amended complaint both assert various product-liability theories, including negligence and warranty claims.
  • Court granted premotion conference request, allowed an amended complaint, and defendants moved to dismiss for failure to state a claim.
  • Amended complaint ties Reed’s injuries to DVT, pulmonary embolus, and related health harms after Lybrel use.
  • FDA-approved warnings for Lybrel are identified by the court as the relevant warnings; plaintiffs fail to plead inadequacies with specificity.
  • Court grants dismissal without prejudice, with leave to amend one final time.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Failure to warn viability Reed alleges inadequate warnings and misrepresentation to FDA/medical community. Warnings were adequate; plaintiff fails to plead how warnings were insufficient. Failure to warn claim dismissed; insufficient factual detail about inadequate warnings.
Manufacturing defect sufficiency Lybrel was negligently manufactured. No facts showing a defect in the particular administered drug. Manufacturing defect claim dismissed for lack of supporting facts.
Design defect viability Lybrel's design was defective and unreasonably risky. Lybrel’s design lacked factual support; no feasible safer alternative design pled. Design defect claim dismissed; no feasible alternative design pled.
Breach of express/implied warranties Warranties claimed that Lybrel was tested, merchantable, and safe for use. Allegations fail to show defective product or breach of a specific warranty. Breach of express and implied warranty claims dismissed; lack of plausible warranty breach facts.

Key Cases Cited

  • Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (U.S. 2007) (pleading must show facial plausibility, not mere possibility)
  • Ashcroft v. Iqbal, 556 U.S. 662 (U.S. 2009) (pleadings must show plausible claims with factual support)
  • Skinner v. Switzer, 131 S. Ct. 1289 (U.S. 2011) (plausibility remains key; pleadings need factual content)
  • Horowitz v. Stryker Corp., 613 F. Supp. 2d 271 (E.D.N.Y. 2009) (adequacy of warranty representations requires description of the misrepresentation)
Read the full case

Case Details

Case Name: Reed v. Pfizer, Inc.
Court Name: District Court, E.D. New York
Date Published: Mar 14, 2012
Citation: 2012 U.S. Dist. LEXIS 35227
Docket Number: No. 10-CV-05356 (ENV)(RER)
Court Abbreviation: E.D.N.Y